Holen Sie sich die Stockscreener-App
2.72
1.87%
0.05
Finanzdaten der C 4 Therapeutics Inc-Aktie (CCCC)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
10.71%
6.463
|
7.238 | 15.36 | 12.01 | 3.039 |
Operating Expenses
|
3.95%
34.96
|
36.40 | 43.61 | 33.45 | 35.26 |
| Benefits Costs and Expenses |
3.21%
32.48
|
33.56 | 40.03 | 29.72 | 31.40 |
| Costs And Expenses |
3.21%
32.48
|
33.56 | 40.03 | 29.72 | 31.40 |
| Operating Income/Loss |
2.27%
-28.50
|
-29.16 | -28.24 | -21.44 | -32.22 |
| Nonoperating Income/Loss |
12.70%
2.481
|
2.842 | 3.578 | 3.726 | 3.858 |
| Income/Loss From Continuing Operations Before Tax |
1.15%
-26.02
|
-26.32 | -24.67 | -17.72 | -28.36 |
| Income Tax Expense/Benefit |
-
|
- | - | - | - |
| Income/Loss From Continuing Operations After Tax |
1.15%
-26.02
|
-26.32 | -24.67 | -17.72 | -28.36 |
|
Net Income/Loss
|
1.15%
-26.02
|
-26.32 | -24.67 | -17.72 | -28.36 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
0.24%
71.01
|
70.83 | 69.63 | 68.81 | 68.43 |
| Diluted Average Shares |
0.24%
71.01
|
70.83 | 69.63 | 68.81 | 68.43 |
| Basic Earnings Per Share |
0.00%
-0.37
|
-0.37 | -0.35 | -0.26 | -0.41 |
| Diluted Earnings Per Share |
0.00%
-0.37
|
-0.37 | -0.35 | -0.26 | -0.41 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
1.40%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):